Table 1 Clinico-pathological data of squamous-differentiated bladder cancers used in this study (Sq-BLCA; n = 125).
From: EGFR activity addiction facilitates anti-ERBB based combination treatment of squamous bladder cancer
Variables | SCC (n = 75) | MIX-SCC (n = 50) |
|---|---|---|
Patient age (years) | ||
30–49 | 11 | 3 |
50–69 | 32 | 18 |
70–99 | 29 | 26 |
na | 3 | 3 |
Gender | ||
Female | 35 | 28 |
Male | 36 | 19 |
na | 4 | 3 |
Tumor stage | ||
pT1 | 1 | 0 |
pT2 | 11 | 6 |
pT3 | 43 | 36 |
pT4 | 13 | 5 |
pTx | 7 | 3 |
Tumor grade | ||
G1 | 1 | 0 |
G2 | 26 | 10 |
G3 | 44 | 35 |
G4 | 0 | 2 |
na | 4 | 3 |
Nodal status | ||
N0 | 44 | 29 |
N1 | 8 | 6 |
N2 | 4 | 5 |
na | 19 | 10 |
